AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Mark F Brady

Mark F Brady

Roswell Park Comprehensive Cancer Center - Buffalo / United States
Others
AD Scientific Index ID: 4607065
Roswell Park Cancer Institute
person_outline Mark F Brady's MOST POPULAR ARTICLES
1-) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer New England Journal of Medicine 334 (1), 1-6, 1996
2-) Incorporation of bevacizumab in the primary treatment of ovarian cancer New England Journal of Medicine 365 (26), 2473-2483, 2011
3-) The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma American journal of obstetrics and gynecology 170 (4), 974-980, 1994
4-) Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer New England Journal of Medicine 381 (25), 2403-2415, 2019
5-) Prognostic factors in early‐stage uterine sarcoma: a Gynecologic Oncology Group Study Cancer 71 (S4), 1702-1709, 1993